Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
01/1996
01/25/1996WO1996001652A1 Aqueous risperidone formulations
01/25/1996WO1996001650A1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate
01/25/1996WO1996001637A1 New pharmaceutical preparation for pain management
01/25/1996WO1996001634A1 Long-acting oxytetracycline composition
01/25/1996WO1996001628A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension
01/25/1996WO1996001626A1 Transdermal drug delivery system
01/25/1996WO1996001623A1 Multiple unit tableted dosage form i
01/25/1996WO1996001570A1 Cold water-dispersible compositions of fat-soluble active substances
01/25/1996WO1996001558A1 Anandamide analogue compositions and method of treating intraocular hypertention using same
01/25/1996DE4426709A1 Steroidale Sexualhormone enthaltende feste Arzneiformen Sex steroid-containing solid dosage forms
01/25/1996DE4425322A1 Virostatics in a hydrophobic base for topical use
01/25/1996CA2194796A1 Cold water-dispersible compositions of fat-soluble active substances
01/25/1996CA2194460A1 Melt-processible poly(ester urethane) and a process for the preparation thereof
01/25/1996CA2194374A1 Pharmaceutical composition for the controlled release of moguisteine in a liquid suspension
01/25/1996CA2193992A1 New pharmaceutical preparation for pain management
01/25/1996CA2193263A1 Adenovirus comprising a gene coding for an no synthase
01/24/1996EP0693284A1 Prostacyclin-containing oleaginous ointment
01/24/1996EP0693282A2 Duloxetine enteric pellets
01/24/1996EP0693281A2 Fluoxetine Pharmaceutical formulations
01/24/1996EP0693130A1 Targeted delivery of genes encoding antisense polyribonucleotides
01/24/1996EP0693079A1 Derivatives of triterpenoid acids and uses thereof
01/24/1996EP0631617A4 Colon crypt cell mitogen, cell line producing it, and uses thereof.
01/24/1996CN1115564A Polymer-bound camptothecin derivatives
01/24/1996CN1115252A Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides
01/23/1996US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups
01/23/1996US5486537 Cinnamic aldehyde, griseofluvin, alcohol
01/23/1996US5486508 Cyclodextrin composition
01/23/1996US5486507 Porous particle aggregate and method therefor
01/23/1996US5486365 Calcium hydrogen phosphate, a method for preparing it, and an excipient utilizing it
01/23/1996US5486364 Readily available konjac glucomannan as a sustained release excipient
01/23/1996CA1337970C Antibacterial adhesive composition
01/18/1996WO1996001129A1 Inclusion complexes of ranitidine
01/18/1996WO1996001128A2 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets
01/18/1996WO1996001119A1 Antimicrobial compositions useful for medical applications
01/18/1996WO1996001112A1 Carbamazepine medicament with retarded active substance release
01/18/1996WO1996001102A1 Factor to grow tissue ex vivo
01/18/1996WO1995034302A3 Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
01/18/1996DE4424085A1 Kaltwasserdispergierbare Zubereitungen fettlöslicher Wirkstoffe Kaltwasserdispergierbare preparations of fat-soluble substances
01/18/1996CA2194371A1 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets
01/18/1996CA2194216A1 Carbamazepine medicament with retarded active substance release
01/18/1996CA2194057A1 Factor to grow tissue ex vivo
01/17/1996EP0692506A2 Thermo-sensitive polyether polyurethane, production method thereof and thermo-sensitive composition
01/17/1996EP0692255A2 Antacid preparation with improved safety profile
01/17/1996EP0692249A1 Compounds bearing one or more oxime functions, stabilized in aqueous solution, process to prepare them, and their use as drugs
01/17/1996EP0692242A1 Use of deformable hollow particles in a cosmetic and/or dermatological composition containing fatty substance
01/17/1996EP0692241A1 Gelified, rich in solvent cosmetic and/or dermatological composition containing hollow particles
01/17/1996EP0692096A1 Determination of concentration by affinity titration and competitive displacement in drug delivery
01/17/1996EP0692029A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy
01/17/1996EP0691992A1 Random block copolymers
01/17/1996EP0691990A1 Amphoteric copolymer derived from vinylpyridine & acetoxystyrene
01/17/1996EP0691976A1 Anticoagulant compounds
01/17/1996EP0691886A1 Microcapsules with walls made of cross-linked plant polyphenols, and compositions containing same
01/17/1996EP0691854A1 Conjugates of proteins and bifunctional ligands
01/17/1996EP0691852A1 Prodrugs with enhanced penetration into cells
01/17/1996EP0691844A1 Method for treating amyloidosis
01/17/1996EP0691828A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
01/17/1996EP0674646A4 Lipid derivatives of phosphonoacids for liposomal incorporation and method of use.
01/17/1996EP0577659B1 Cross-linking agent
01/17/1996EP0522128B1 Water-dispersible tablets
01/17/1996CN1114903A A styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen
01/17/1996CN1114879A Method of administering azithromycin
01/16/1996US5484913 Surgical equipment
01/16/1996US5484907 Nucleotides coding for the extracellular membrane-bound segment of IgA
01/16/1996US5484893 Tri-aza macrocycles and metal complexes thereof
01/16/1996US5484816 Stabilized vitamin a composition
01/16/1996US5484809 Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid
01/16/1996US5484801 Pharmaceutical composition for inhibiting HIV protease
01/16/1996US5484776 Process for the production of stable liquid form of beta-blocker-containing medicaments with controlled release of the active constituent for oral administration
01/16/1996US5484773 Treatment of antibiotic associated diarrhea
01/16/1996US5484704 Screening tissues for cancer cells
01/16/1996US5484606 Stability
01/16/1996US5484584 Therapeutic and diagnostic use of modified polymeric microcapsules
01/16/1996CA2074454C Medicine based on neutralized sulphur derivatives
01/16/1996CA2017281C Modified polyester composition and preparation process and use thereof
01/14/1996CA2153567A1 Antacid formulation having an improved safety profile
01/14/1996CA2153553A1 Stable lipid emulsion
01/11/1996WO1996000792A1 Use of a bacterial component to enhance targeted delivery of polynucleotides to cells
01/11/1996WO1996000783A1 Antibodies which bind to insect gut proteins and their use
01/11/1996WO1996000760A1 pH-MODIFIED BIOCOMPATIBLE MONOMER AND POLYMER COMPOSITIONS
01/11/1996WO1996000585A1 Diphosphate or triphosphate analogue conjugates
01/11/1996WO1996000567A1 Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation
01/11/1996WO1996000537A1 Microcapsules for administration of neuroactive agents
01/11/1996WO1996000506A1 Stabilized composition comprising colistin sulfate
01/11/1996WO1996000503A1 Novel peptides
01/11/1996CA2193968A1 Ph-modified biocompatible monomer and polymer compositions
01/11/1996CA2193859A1 Antibodies which bind to insect gut proteins and their use
01/11/1996CA2192957A1 Semenogelin-derived oligopeptides cleavable by prostate specific antigen
01/10/1996EP0691407A1 Non-reducing saccharide and its production and use
01/10/1996EP0691344A1 Purification of trehalose
01/10/1996EP0690722A1 Composition and method for reducing toxicity of biologically-active factors
01/10/1996EP0690719A1 Dry mix formulation for bisphosphonic acids
01/10/1996EP0656026A4 Polyarylates containing derivatives of the natural amino acid l-tyrosine.
01/10/1996EP0630236B1 Self-assembling diketopiperazine drug delivery system
01/10/1996EP0610441A4 Crosslinkable polysaccharides, polycations and lipids useful for encapsulation and drug release.
01/10/1996EP0609321B1 Stabilized calorific nutrient solution and multi-chamber system for the parenteral feeding of humans
01/10/1996EP0605578B1 Pressurised aerosol compositions
01/10/1996EP0599850B1 Composition and method for treating cystic fibrosis
01/10/1996EP0527946B1 Controlled release vehicle
01/10/1996EP0471084B1 Oil-in-water emulsion composition containing nonsteroidal antiphlogistic analgesic
01/10/1996CN1114824A 1 alpha, 24-(OH)2-vitamin D3 emulsion composition